ArticleAmerican journal of translational research2026
Effects of levofloxacin combined with dexamethasone ear drops on suppurative otitis media and analysis of influencing factors.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the effects of levofloxacin combined with dexamethasone ear drops on suppurative otitis media (SOM) and factors influencing the effects.
methodsA total of 149 patients with SOM admitted to Liangxiang Hospital, Fangshan District were selected and allocated to the control group (n = 70, treated with levofloxacin) or the research group (n = 79, treated with levofloxacin combined with dexamethasone ear drops) in this retrospective study. The following parameters were collected from both groups: treatment efficacy, pathogen clearance rate, adverse reactions, hearing metrics, time to symptom resolution, and serum biochemical parameters. Subsequently, univariate and multivariate analyses were performed to assess factors influencing treatment efficacy.
resultsThe total effective rate (P = 0.001) and pathogen clearance rate (P = 0.012) in the research group were notably higher than those in the control group, while the overall incidence of adverse reactions (P = 0.005), post-treatment hearing metrics (P < 0.05), time to symptom resolution (P < 0.01), and serum biochemical parameters (P < 0.05) were notably lower than those in the control group. Univariate and multivariate analyses identified tympanic membrane perforation size (P = 0.003), disease activity (P = 0.040), and treatment method (P = 0.004) as independent factors influencing treatment efficacy in SOM patients.
conclusionLevofloxacin combined with dexamethasone ear drops has a significant effect on SOM. For patients with active purulent ear discharge, and large tympanic membrane perforation, levofloxacin combined with dexamethasone has a lower risk of treatment failure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.